Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Macao Business Journal.
Press releases published on September 3, 2025
تتعاون شركة Synopsis مع Telnyx لطرح تقنيات اتصالات قابلة للتوسع وVoice AI في منطقة الشرق الأوسط وشمال إفريقيا
GlobeNewswire
·
September 3, 2025
AUSTIN, Sept. 03, 2025 (GLOBE NEWSWIRE) -- أعلنت Telnyx، المنصة المتكاملة للذكاء الاصطناعي الحواري التي تدعم الاتصالات العالمية، عن عقد شراكة جديدة مع Synopsis، الموزع الرائد للتكنولوجيا في أسواق الشرق الأوسط وإفريقيا. سيفتح هذا التعاون آفاقًا جديدةً …
Breckenridge Distillery Expands California Distribution with Winebow
GlobeNewswire
·
September 3, 2025
BRECKENRIDGE, Colo., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), has announced a strategic change in its California distribution …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 3, 2025
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted nine newly-hired employees stock options to purchase an …
Climb Channel Solutions Announces North American Distribution Partnership with Forcepoint to Deliver Data Security Everywhere
GlobeNewswire
·
September 3, 2025
EATONTOWN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) announces North American Distribution Partnership with …
TScan Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
September 3, 2025
WALTHAM, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …
Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, …
OTC Markets Group Welcomes Bonvenu Bancorp, Inc. to OTCQX
GlobeNewswire
·
September 3, 2025
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bonvenu Bancorp, Inc. (OTCQX: BBNA), the holding company for Bonvenu Bank …
OTC Markets Group Welcomes Empire Metals LTD to OTCQX
GlobeNewswire
·
September 3, 2025
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Empire Metals LTD (AIM: EEE; OTCQX: EPMLF), an exploration and resource …
Istios Health Partners with Infectious Diseases Associates of Central Virginia
GlobeNewswire
·
September 3, 2025
PHOENIX, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Istios Health, a healthcare technology company transforming infectious disease (ID) and related care through integrated clinical services, real-world data, and research-enabled networks, today announced a …
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary
GlobeNewswire
·
September 3, 2025
WATERTOWN, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the …
Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth
GlobeNewswire
·
September 3, 2025
BURLINGTON, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today …
New Research Highlights Both the Importance and Challenges of Student Engagement in K-12 Education
GlobeNewswire
·
September 3, 2025
Charlotte, NC, Sept. 03, 2025 (GLOBE NEWSWIRE) -- A new study reveals that while there is wide agreement that student engagement plays a vital role in learning, educators continue to face uncertainty about what engagement looks like, how best to measure it …
Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 3, 2025
BOSTON and LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its …
Sono-Tek Wins Order for Medical Device Coating Systems Valued at Over $5 Million
GlobeNewswire
·
September 3, 2025
MILTON, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it has received a multi-million dollar purchase order, valued at over $5 …
C4 Therapeutics to Present Data from the Phase 1 Trial of Cemsidomide in Multiple Myeloma at the International Myeloma Society (IMS) Annual Meeting
GlobeNewswire
·
September 3, 2025
WATERTOWN, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that data from its Phase 1 dose …
Amplify ETFs Declares August Income Distributions for Bitcoin Option Income ETFs
GlobeNewswire
·
September 3, 2025
CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Amplify ETFs announces August income distribution for its Bitcoin* option income ETFs, BITY and BAGY. ETF Name Ticker Distribution Rate1 Amount per Share Distribution Frequency 30 Day SEC Yield1 Amplify Bitcoin …
MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
LA JOLLA, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that …
ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310
GlobeNewswire
·
September 3, 2025
Cohort 2 fully enrolled; enrollment and dosing now underway for Cohort 3 (final dose level); No cases of amyloid-related imaging abnormalities (ARIA) observed to date; The trial, expected to enroll 128 patients, remains on track to report 6-month interim …
Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors
GlobeNewswire
·
September 3, 2025
SEATTLE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced that its Board …
Talisker Receives Preliminary Results from the Second Phase of Ore Sorting Studies for the Bralorne Gold Project
GlobeNewswire
·
September 3, 2025
TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) is pleased to announce preliminary results from the second stage of laser-based ore-sorting of material from the Company’s Bralorne …